-
Signature
-
/s/ Samantha Eldredge, as Attorney-in-Fact
-
Issuer symbol
-
KYTX
-
Transactions as of
-
15 Dec 2025
-
Net transactions value
-
-$176,865
-
Form type
-
4
-
Filing time
-
17 Dec 2025, 20:30:03 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Walker Karen Marie |
Chief Technology Officer |
C/O KYVERNA THERAPEUTICS, INC., 5980 HORTON ST., STE 550, EMERYVILLE |
/s/ Samantha Eldredge, as Attorney-in-Fact |
17 Dec 2025 |
0002008556 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
KYTX |
Common Stock |
Options Exercise |
$115,910 |
+23,998 |
+106% |
$4.83 |
46,634 |
15 Dec 2025 |
Direct |
F1 |
| transaction |
KYTX |
Common Stock |
Sale |
$292,776 |
-23,998 |
-51% |
$12.20 |
22,636 |
15 Dec 2025 |
Direct |
F1 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
KYTX |
Stock option (right to buy) |
Options Exercise |
$0 |
-23,998 |
-22% |
$0.000000 |
85,865 |
15 Dec 2025 |
Common Stock |
23,998 |
$4.83 |
Direct |
F1, F2 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: